How should hyponatremia be managed and corrected, distinguishing acute versus chronic cases, assessing severity and symptoms, and what are the recommended correction rates, treatment options, and measures to avoid overcorrection?

Management and Correction of Hyponatremia

Immediate Assessment: Distinguish Acute from Chronic and Assess Symptom Severity

The single most critical decision is determining whether hyponatremia is acute (<48 hours) or chronic (>48 hours), as this fundamentally changes correction rates and risk of complications. 1, 2

Acute Hyponatremia (<48 hours)

• Defined by sodium decrease >0.5 mmol/L/hour or large fluid intake within 2-3 days 3
• Can be corrected rapidly without osmotic demyelination risk 1, 3
• Requires urgent intervention if symptomatic 2

Chronic Hyponatremia (>48 hours)

• Most common presentation; assume chronic if timing unknown 1, 3
• Requires slower, controlled correction to prevent osmotic demyelination syndrome 1, 4
• Maximum 8 mmol/L correction in 24 hours 1, 5

Symptom Severity Classification

Severe symptoms (medical emergency requiring immediate hypertonic saline): 1, 6

• Seizures, coma, altered consciousness
• Cardiorespiratory distress
• Somnolence or obtundation

Moderate symptoms: 1, 7

• Nausea, vomiting, confusion
• Headache, lethargy

Mild/asymptomatic: 1, 7

• Weakness, gait instability
• Cognitive impairment (chronic cases)

---

Treatment Based on Severity and Acuity

Severe Symptomatic Hyponatremia (Emergency Management)

Administer 100 mL of 3% hypertonic saline IV over 10 minutes immediately, repeating every 10 minutes up to 3 total boluses if symptoms persist. 1, 6, 7

Target correction: 4-6 mmol/L increase within first 1-2 hours or until symptoms resolve 6, 7, 4

Absolute maximum: 8 mmol/L rise in any 24-hour period for chronic hyponatremia 1, 6, 5

Monitoring during acute phase:

• Check serum sodium every 2 hours during initial correction 1, 6
• Switch to every 4-6 hours after symptom resolution 1
• Strict intake/output monitoring 6

After initial stabilization:

• Switch from 3% saline to isotonic (0.9%) saline for maintenance 1
• Avoid hypotonic fluids (0.45% saline, lactated Ringer's, D5W) 1, 8

---

Chronic Hyponatremia: Correction Rate Guidelines

Standard-risk patients: 4-8 mmol/L per day, maximum 10-12 mmol/L in 24 hours 1

High-risk patients (advanced liver disease, alcoholism, malnutrition, prior encephalopathy): 1, 5, 4

• Maximum 4-6 mmol/L per day
• Absolute ceiling of 8 mmol/L in 24 hours
• Risk of osmotic demyelination syndrome remains 0.5-1.5% even with careful correction 1

Critical pitfall: Overcorrection >12 mmol/L in 24 hours causes osmotic demyelination syndrome with dysarthria, dysphagia, quadriparesis, seizures, coma, or death 1, 5, 4

---

Treatment Based on Volume Status

Hypovolemic Hyponatremia

Diagnostic clues: 1

• Urine sodium <30 mmol/L (71-100% predictive of saline responsiveness)
• Orthostatic hypotension, dry mucous membranes, decreased skin turgor
• Elevated BUN:creatinine ratio >20:1

Treatment: 1, 8

• Discontinue diuretics immediately
• Administer isotonic saline (0.9% NaCl) for volume repletion
• Initial rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on response
• Still respect 8 mmol/L/24-hour correction limit

---

Euvolemic Hyponatremia (SIADH)

Diagnostic criteria: 1, 8

• Serum osmolality <275 mOsm/kg
• Urine osmolality >100 mOsm/kg (typically >300 mOsm/kg)
• Urine sodium >20-40 mmol/L
• Clinical euvolemia (no edema, normal BP, moist mucous membranes)
• Normal thyroid, adrenal, renal function

Treatment hierarchy: 1, 7

1. Mild/asymptomatic: Fluid restriction to 1 L/day (first-line) 1, 8

2. If fluid restriction fails: Add oral sodium chloride 100 mEq three times daily 1

3. Pharmacologic options for resistant cases: 1, 7

   • Urea (effective but poor palatability)
   • Vaptans (tolvaptan 15 mg daily, titrate to 30-60 mg)
   • Loop diuretics, demeclocycline, lithium (less commonly used)

4. Severe symptomatic SIADH: 3% hypertonic saline as above 1, 8

Vaptan (tolvaptan) considerations: 5, 7

• FDA-approved for euvolemic/hypervolemic hyponatremia
• Must initiate in hospital with close sodium monitoring
• Risk of overly rapid correction (7% had >8 mmol/L rise at 8 hours)
• Maximum 30-day use to minimize hepatotoxicity risk
• Contraindicated with strong CYP3A inhibitors

---

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

Pathophysiology: Non-osmotic vasopressin release despite total body sodium/water excess 1

Treatment: 1, 7

1. Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L (first-line) 1

2. Discontinue diuretics temporarily if sodium <125 mmol/L 1

3. Cirrhotic patients: Consider albumin infusion (8 g/L of ascites removed) alongside fluid restriction 1

4. Avoid hypertonic saline unless life-threatening symptoms present (worsens ascites/edema) 1

5. Vaptans may be considered for persistent severe hyponatremia despite fluid restriction and optimized guideline-directed therapy 1, 7

Key principle: Sodium restriction (not fluid restriction) drives weight loss in cirrhosis, as fluid follows sodium 1

---

Special Populations and Scenarios

Neurosurgical Patients: SIADH vs. Cerebral Salt Wasting (CSW)

Critical distinction: These require opposite treatments—misdiagnosis is potentially fatal 1

SIADH characteristics: 1

• Euvolemic (CVP 6-10 cm H₂O)
• Urine sodium >20-40 mmol/L
• Urine osmolality >300 mOsm/kg
• Treatment: Fluid restriction

CSW characteristics: 1

• Hypovolemic (CVP <6 cm H₂O, orthostatic hypotension)
• Urine sodium >20 mmol/L despite volume depletion
• Clinical signs: dry mucous membranes, flat neck veins
• Treatment: Volume and sodium replacement with isotonic/hypertonic saline

CSW management: 1

• Aggressive volume replacement (50-100 mL/kg/day normal saline)
• Severe cases: 3% hypertonic saline + fludrocortisone 0.1-0.2 mg daily
• Never use fluid restriction—worsens outcomes and increases cerebral ischemia risk

Subarachnoid hemorrhage patients at vasospasm risk: 1

• Avoid fluid restriction (increases ischemic complications)
• Consider fludrocortisone or hydrocortisone to prevent natriuresis

---

Cirrhotic Patients

Hyponatremia prevalence: 21.6% have sodium ≤130 mmol/L; only 1.2% have ≤120 mmol/L 1

Clinical significance: Sodium ≤130 mmol/L increases risk of: 1

• Spontaneous bacterial peritonitis (OR 3.40)
• Hepatorenal syndrome (OR 3.45)
• Hepatic encephalopathy (OR 2.36)

Correction strategy: 1

• Maximum 4-6 mmol/L per day (more conservative than standard)
• Absolute ceiling 8 mmol/L in 24 hours
• Higher osmotic demyelination risk than general population

---

Management of Overcorrection

If sodium rises >8 mmol/L in 24 hours: 1, 4

1. Immediately discontinue current fluids
2. Switch to D5W (5% dextrose in water) to relower sodium
3. Administer desmopressin to slow/reverse rapid rise
4. Target: Bring total 24-hour correction back to ≤8 mmol/L from baseline

Osmotic demyelination syndrome signs (appear 2-7 days post-correction): 1, 5

• Dysarthria, dysphagia
• Oculomotor dysfunction
• Spastic quadriparesis
• Seizures, coma

---

Common Pitfalls to Avoid

1. Ignoring mild hyponatremia (130-135 mmol/L): Associated with 60-fold increased mortality, falls (21% vs 5%), cognitive impairment, and fractures 1, 9, 7

2. Correcting chronic hyponatremia >8 mmol/L in 24 hours: Causes osmotic demyelination syndrome 1, 5, 4

3. Using fluid restriction in CSW or subarachnoid hemorrhage with vasospasm risk: Worsens cerebral ischemia 1

4. Applying hypertonic saline to hypervolemic hyponatremia without severe symptoms: Worsens fluid overload 1

5. Inadequate monitoring during active correction: Check sodium every 2 hours initially 1, 6

6. Failing to identify and treat underlying cause: Leads to recurrence 1

7. Using hypotonic fluids (lactated Ringer's, 0.45% saline) during correction: Worsens hyponatremia 1, 8